Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00076713 · ClinicalTrials.gov registry record
Antiphospholipid Syndrome Collaborative Registry (APSCORE)
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 860
- Enrollment target
NCT00076713 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 860 participants.
The verdict
NCT00076713 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 860 participants
- Enrollment target
Study Summary
Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies against them. Patients with these antibodies may experience miscarriages and blood clotting disorders, including heart attacks and strokes. APS may occur in people with systemic lupus erythematosus and other autoimmune diseases, or in otherwise healthy individuals. The Antiphospholipid Syndrome Collaborative Registry (APSCORE) is a national registry and tissue repository for patients with APS. This registry will collect clinical information and blood samples from people with APS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 860 participants |
| Start Date | 2000-04 |
| Est. Completion | 2007-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00076713
The ClinicalTrials.gov registry entry for NCT00076713 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 860 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00076713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00076713 about?
NCT00076713 is a clinical study titled "Antiphospholipid Syndrome Collaborative Registry (APSCORE)". Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies against them. Patients with these antibodies may experience miscarriages and blood clotting disorders, includi...
What is the current status of trial NCT00076713?
This trial is currently completed. The enrollment target is 860 participants. The study started on 2000-04. Estimated completion is 2007-04.
Who is sponsoring clinical trial NCT00076713?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.